Bacteria and Fungi in Your Gut Recover at Completely Different Rates After Colorectal Surgery

When surgeons operate on the colon or rectum, the gut microbiome takes a hit that goes well beyond temporary discomfort. A prospective longitudinal cohort study published in MedComm by S. Wetzel, E. Kohnert, R. Huber, and colleagues at University Hospital LMU Munich and affiliated institutions has now mapped exactly what happens to both bacterial and fungal populations after colorectal surgery – and the picture is more complicated than anyone had assumed. The two kingdoms of microorganisms do not bounce back together; they follow divergent trajectories, and that divergence may hold the key to improving postoperative outcomes.

Bacterial and Fungal Gut Microbiota Show Divergent Post-Surgical Resilience

The core finding is straightforward but striking: bacterial and fungal communities in the gut respond to colorectal surgery in fundamentally different ways. The study tracked specific changes in microbial composition at multiple time points after surgery, revealing that the two kingdoms do not simply decline and then rebound in parallel. Their recovery patterns – what the researchers call "resilience" – are divergent.

This is not entirely surprising in light of what is already known about post-surgical gut microbiota alterations. Prior research has shown reductions in Bacteroidetes and Firmicutes alongside increases in Proteobacteria on the bacterial side, while fungal communities see decreases in Candida and Saccharomyces paired with increases in Pichia. What Wetzel and colleagues add is a granular longitudinal view of these trajectories unfolding in real time within the same cohort of colorectal surgery patients.

Additionally, as research on colorectal surgery's impact on gut microbiota has documented, the surgical event triggers a marked decrease in beneficial butyrate-producing bacteria alongside a rise in conditional pathogens such as Escherichia-Shigella and Streptococcus. The new study situates this bacterial disruption against a fungal landscape that appears to operate on its own independent clock.

Why Divergent Microbial Recovery Matters for Surgical Patients

The stakes here are clinical and immediate. Roughly 150,000 colorectal surgeries are performed annually in the United States alone, and postoperative complications remain a significant source of morbidity and extended hospital stays. A disrupted microbiome is not merely an abstract biological concern: gut microbiota imbalances after gastrointestinal surgery are linked to infections, anastomotic leak, gastrointestinal dysmotility, malabsorption, and even cancer recurrence.

The problem is that most interventions designed to support gut health after surgery – probiotics, dietary modifications, targeted antibiotic stewardship – were developed with bacteria almost exclusively in mind. If fungi are recovering on a different schedule, and if fungal overgrowth during a window of bacterial weakness contributes to complications, then single-kingdom strategies may be leaving patients underserved. Research has also shown that pre-operative microbiome characteristics predict postoperative outcomes, with low microbial diversity and a higher dysbiosis index independently linked to greater morbidity and longer hospitalization. Understanding what happens to both bacteria and fungi after the scalpel touches tissue is therefore a prerequisite for designing interventions that actually work.

Prospective Longitudinal Design as the Methodological Backbone

What gives this study credibility is its prospective longitudinal design. Rather than collecting microbiome samples at a single post-surgical snapshot or relying on retrospective chart review, the team followed the same cohort forward in time, sampling both bacterial and fungal communities at defined intervals after surgery. This approach is essential for capturing resilience – a concept that only makes sense when you can observe the trajectory from disruption through partial recovery toward a new equilibrium, or the failure to reach one.

Longitudinal microbiome study designs carry a well-recognized advantage: they allow researchers to control for individual baseline differences and observe how the same host's microbial ecosystem shifts across time, isolating the effect of the intervention rather than comparing dissimilar individuals at a single moment. For a question as specific as "do bacteria and fungi recover at the same rate after colorectal surgery," a cross-sectional design would be nearly useless. The longitudinal framework is what makes it possible to define divergence at all.

The cohort included patients undergoing colorectal surgery at University Hospital LMU Munich and partner institutions, with affiliations spanning the Technical University of Munich and the University Hospital Würzburg, among others.

Open Questions About Fungal Dynamics and Clinical Translation

The study's findings also surface a fundamental gap in the field. As researchers studying dysbiosis after gastrointestinal surgery have noted, the understanding of preoperative dysbiosis and post-surgical microbiota recovery remains limited, hindering the development of standardized assessment methods and prevention strategies for complications. Most clinical protocols do not yet account for the mycobiome – the fungal component of the gut – at all.

The Wetzel study does not resolve questions about causality. It maps divergent resilience but stops short of demonstrating that fungal trajectories directly cause specific complications or that correcting them would change outcomes. The sample size, while sufficient for a prospective cohort capturing a real clinical population, is also limited compared to what would be needed to stratify by surgical approach, cancer stage, antibiotic regimen, or patient comorbidities – all variables that could meaningfully influence both bacterial and fungal dynamics.

Microbiome-Targeted Interventions as the Next Frontier in Colorectal Care

The immediate research priority signaled by this work is to move from description to intervention. Future gut microbiome research in colorectal surgery will need to clarify the precise composition of both bacterial and fungal communities before and after surgery, establish how those compositions relate to specific complications, and test targeted interventions. Antifungal prophylaxis, mycobiome-aware probiotic formulations, and dietary strategies that support both kingdoms simultaneously are all plausible candidates that have not yet been evaluated in rigorous trials.

Looking further ahead, multiomics approaches that characterize microbial functional pathways alongside taxonomic identity could reveal not just who is present in the gut after surgery, but what those microbes are doing – whether they are producing beneficial metabolites, driving inflammation, or competing with each other in ways that matter for anastomotic healing and immune function. The Wetzel study plants a flag: bacteria and fungi are not interchangeable in their responses to surgical trauma, and any serious attempt to leverage the microbiome for better surgical outcomes will have to reckon with both kingdoms at once.